MGIGLAB
LIVE

Serial Number

79307670

Owner

MGI TECH CO., LTD.

Attorney

Charles Ho

Filing Date

Dec 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MGIGLAB Trademark

Serial Number: 79307670 • Registration: 6749205

MGIGLAB is a trademark filed by MGI TECH CO., LTD. on December 22, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MGI TECH CO., LTD. (35 trademarks)

Main Building and Second Floor of

Entity Type: 99

Trademark Details

Filing Date

December 22, 2020

Registration Date

June 7, 2022

Published for Opposition

February 1, 2022

Goods & Services

Nucleic acid sequencers used for analyzing nucleic acids in scientific research; Apparatus and measuring instruments for physical and chemical test and composition analysis, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics and contaminants all for scientific purposes; DNA chips; Gene amplification instrument for scientific research purposes; Laboratory apparatus and instruments, namely, gene analyzers for genome information; Testing apparatus not for medical purposes namely, research laboratory analyzers for testing blood and other bodily fluids and electronic apparatus for testing the sterility of pharmaceuticals and injectable solutions; Laboratory equipment, namely, protein sequence analysis apparatus; Diagnostic apparatus, not for medical purposes, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; Computer operating programs, recorded; Downloadable computer programs for biological data mining; Downloadable computer programs for developing bioinformatics database for others; Downloadable computer programs for analyzing genome information

Bacterial preparations for medical and veterinary use; Chemico-pharmaceutical preparations for medical purposes, namely, for the treatment of cancer and genetic diseases; Cultures of microorganisms for medical or veterinary use; Enzyme preparations for medical purposes; Biological tissue cultures for medical purposes; Biochemical pharmaceuticals for medical purposes, namely, for the treatment of cancer and genetic diseases; Blood products for medical purposes, namely, blood plasma and cord blood; Medical diagnostic reagents; Chemical reagents for medical or veterinary purposes; Preparations for detecting genetic predispositions for medical purposes

Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical reagents, other than for medical or veterinary purposes; Test paper, chemical; Radioactive elements for scientific purposes; Cultures of microorganisms, other than for medical and veterinary use; Biological preparations, other than for medical or veterinary purposes, namely, for use in industry and science; Acids, namely, nucleic acid for laboratory use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use

Medical apparatus for detecting gene, namely, flow cytometers and flow-based analyzers providing cell and particle analysis and detection for medical use; Apparatus for DNA and RNA testing for medical purposes; Probes for medical purposes; Medical apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments, namely, apparatus for detecting tumor cancer and genetic diseases; Medical apparatus and instruments, namely, apparatus for detecting and treating tumors and cancer; Apparatus for use in medical analysis, namely, computerized medical recording and analysis apparatus for the diagnosis and analysis of cancer, genetic diseases and microbial infectious diseases; Testing apparatus for medical purposes, namely, blood testing apparatus, immunochemical testing apparatus; Diagnostic apparatus for medical purposes, namely, diagnostic apparatus for testing blood sugar levels, cancer cells and DNA; X-ray apparatus for medical purposes; Radiological apparatus for medical purposes; Ultrasonic diagnostic apparatus for medical purposes

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jul 11, 2023 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Jun 6, 2023 COC.
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 28, 2023 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 25, 2023 APRE
TEAS SECTION 7 REQUEST RECEIVED
Oct 31, 2022 ES7R
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 20, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 19, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 7, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 7, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2022 R.PR
ELECTRONIC RECORD REVIEW COMPLETE
Apr 29, 2022 FIXD
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2022 REAP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 30, 2022 ERRR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 1, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jan 29, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 12, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 12, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 12, 2022 NONP
ASSIGNED TO LIE
Dec 30, 2021 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 29, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 28, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 13, 2021 GNFN
FINAL REFUSAL E-MAILED
Aug 13, 2021 GNFR
FINAL REFUSAL WRITTEN
Aug 13, 2021 CNFR
REFUSAL PROCESSED BY IB
Jul 19, 2021 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 15, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 1, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 1, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 1, 2021 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 28, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 28, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 24, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 23, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 6, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 1, 2021 REPR